Astrana Health, Inc. · Healthcare · Medical Care Facilities
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$31.75
+$1.15 (+3.74%) 2:29 PM ET
Prev closePrevC$30.60
OpenOpen$30.58
Day highHigh$32.00
Day lowLow$30.58
VolumeVol387,188
Avg volAvgVol413,723
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$1.54B
P/E ratio
67.54
FY Revenue
$3.18B
EPS
0.47
Gross Margin
10.73%
Sector
Healthcare
AI report sections
BULLISH
ASTH
Astrana Health, Inc.
Astrana Health shows solid top-line expansion and positive free cash flow generation but faces compressed profitability and elevated valuation multiples. Recent price action combines short-term upside momentum and multiple bullish breakout signals with a six-month drawdown and heavy short-volume activity, indicating a mixed risk-reward profile. Balance sheet liquidity appears adequate relative to near-term obligations while leverage and weak returns on capital temper the longer-term quality picture.
AI summarized at 4:00 PM ET, 2026-03-02
AI summary scores
INTRADAY:57SWING:49LONG:44
Volume vs average
Intraday (cumulative)
+117% (Above avg)
Vol/Avg: 2.17×
RSI
76.85(Overbought)
Overbought (>70)
0255075100
MACD momentum
Intraday
+0.00 (Strong)
MACD: -0.02 Signal: -0.03
Short-Term
+0.42 (Strong)
MACD: 1.58 Signal: 1.16
Long-Term
+0.52 (Strong)
MACD: 1.56 Signal: 1.04
Intraday trend score
85.01
LOW76.01HIGH85.01
Latest news
ASTH•7 articles•Positive: 2Neutral: 0Negative: 0
PositiveBenzinga• Vandana Singh
UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments
The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.
UNHHUMCVSELVMedicare AdvantageCMS payment rates2027 capitation ratesrisk adjustment model
Sentiment note
Stock rose 5.42% as a Medicare Advantage focused company benefiting from improved payment rates and market predictability
PositiveBenzinga• Prnewswire
Astrana Health, Inc. Reports Second Quarter 2025 Results
Astrana Health reported strong Q2 2025 financial results with total revenue of $654.8 million, up 35% year-over-year, and completed its acquisition of Prospect Health, expanding its healthcare service platform.
Strong revenue growth of 35%, successful Prospect Health acquisition, positive CEO commentary about company's strategic positioning, and reiteration of full-year guidance indicate robust business performance
UnknownZacks Investment Research• Zacks Equity Research
Here is Why Growth Investors Should Buy Astrana Health, Inc. (ASTH) Now
Astrana Health, Inc. (ASTH) possesses solid growth attributes, which could help it handily outperform the market.
ASTH
UnknownZacks Investment Research• Zacks Equity Research
DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 21.43% and 2.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DVAASTH
UnknownZacks Investment Research• Zacks Equity Research
Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates
Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 4.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
OPCHASTH
UnknownBenzinga• Benzinga Insights
Truist Securities Maintains Hold Rating for Astrana Health: Here's What You Need To Know
Truist Securities has decided to maintain its Hold rating of Astrana Health (NASDAQ:ASTH) and raise its price target from $41.00 to $44.00.
Shares of Astrana Health are trading down 1.44% over the last 24 hours, at $44.39 per share.
A move to $44.00 would account for a 0.88% decrease from the current share price.
About Astrana Health
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based ...Full story available on Benzinga.com
ASTHAnalyst Ratings
UnknownZacks Investment Research• Zacks Equity Research
Astrana Health Inc. (ASTH) Q4 Earnings and Revenues Top Estimates
Astrana Health Inc. (ASTH) delivered earnings and revenue surprises of 52.94% and 1.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
ASTHSHCR
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
